In the present cohort, because the tumor number was greater than 3 (score 2), only the patients with AFP levels at or less than 100 ng/mL (score 0) and the largest tumor at or less than 3 cm (score 0) were included (Table S1). This evidence concerns the gene AFP and neoplasm.